Education
About Us
Working with TipRanks
Follow Us
Veru (VERU)
NASDAQ:VERU
Earnings Data
Report Date
Feb 11, 2026Before Open (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
-0.32Last Year’s EPS
-0.6Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call highlighted the successful results from the Phase IIb clinical trial for enobosarm, regulatory clarity for future development, and a positive safety profile, which were overshadowed by financial losses and the need for additional capital.Company Guidance
Successful Phase IIb Clinical Trial for Enobosarm
The enobosarm 3-milligram plus semaglutide group met the primary endpoint with 100% average preservation of total lean mass compared to placebo, with a 12% greater fat loss at 16 weeks.
Positive Safety Profile
The combination of enobosarm and semaglutide showed a positive safety profile with no added gastrointestinal adverse events compared to semaglutide alone.
Regulatory Clarity and Path Forward
FDA provided guidance with two potential regulatory pathways for enobosarm development in combination with GLP-1 receptor agonists, focusing on incremental weight loss or preservation of physical function.
Strong Financial Position for Future Trials
The company ended the fiscal year with $15.8 million in cash and cash equivalents and raised an additional $23.4 million through a public offering.
VERU Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
VERU Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Dec 17, 2025 | $2.44 | $2.23 | -8.61% |
Aug 12, 2025 | $3.59 | $3.17 | -11.70% |
May 08, 2025 | $5.01 | $5.22 | +4.19% |
Feb 13, 2025 | $5.50 | $5.26 | -4.36% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Veru (VERU) report earnings?
Veru (VERU) is schdueled to report earning on Feb 11, 2026, Before Open (Confirmed).
What is Veru (VERU) earnings time?
Veru (VERU) earnings time is at Feb 11, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is VERU EPS forecast?
VERU EPS forecast for the fiscal quarter 2026 (Q1) is -0.32.